BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17683646)

  • 1. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
    JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M; Chidambaram JD; Alemayehu W; Lee DC; Yi EH; Cevallos V; Zhou Z; Donnellan C; Saidel M; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2004 Aug; 292(6):721-5. PubMed ID: 15304470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
    Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
    Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
    PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travel and implications for the elimination of trachoma in ethiopia.
    Shah NA; House J; Lakew T; Alemayehu W; Halfpenny C; Hong KC; Keenan JD; Porco TC; Whitcher JP; Lietman TM; Gaynor BD
    Ophthalmic Epidemiol; 2010 Mar; 17(2):113-7. PubMed ID: 20302432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
    Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.